WHO will recommend vaccination of children from coronavirus by age groups only if the results of the relevant clinical trials, the head of the WHO representative office in Azerbaijan Hand Harmanjani said to journalists.
According to Harmangi, only the effectiveness of the Pfizer vaccine for children over 12 years old is proved.
“The Committee of the European Medicine Agency approved the use of the Vaccine from COVID-19 SpikeVax (earlier Moderna) for children aged 12-17 years. It should be noted that this drug can already be used to vaccinate people over 18 years old. Although that among children likely severe COVID-19 and admission below, there is evidence that children with underlying medical conditions are at increased risk of severe coronavirus disease. In order to fully understand the benefits and risks of vaccination of children, more research is needed on the results will be determined Short-term and long-term consequences of coronavirus disease, vaccine safety indicators for children, “Harmanji said.